Teva Pharmaceutical Industries Ltd
TASE:TEVA
Teva Pharmaceutical Industries Ltd
Interest Income Expense
Teva Pharmaceutical Industries Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
Interest Income Expense
-$991m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-10%
|
Taro Pharmaceutical Industries Ltd
NYSE:TARO
|
Interest Income Expense
$48.5m
|
CAGR 3-Years
23%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
18%
|
|
I
|
InterCure Ltd
TASE:INCR
|
Interest Income Expense
-₪24.2m
|
CAGR 3-Years
-117%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
Mediwound Ltd
NASDAQ:MDWD
|
Interest Income Expense
$9.7m
|
CAGR 3-Years
126%
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
R
|
Rekah Pharmaceutical Industry Ltd
TASE:REKA
|
Interest Income Expense
-₪12.2m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-6%
|
C
|
Cannassure Therapeutics Ltd
TASE:CSURE
|
Interest Income Expense
-₪1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Teva Pharmaceutical Industries Ltd's Interest Income Expense?
Interest Income Expense
-991m
USD
Based on the financial report for Dec 31, 2023, Teva Pharmaceutical Industries Ltd's Interest Income Expense amounts to -991m USD.
What is Teva Pharmaceutical Industries Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-10%
Over the last year, the Interest Income Expense growth was -10%. The average annual Interest Income Expense growth rates for Teva Pharmaceutical Industries Ltd have been -6% over the past three years , -2% over the past five years , and -10% over the past ten years .